The breast imaging market involves diagnostic imaging technologies that are used for early detection and diagnosis of breast cancer. Mammography has been the gold standard for breast cancer screening and comprises X-ray examinations conducted to detect early signs of breast abnormalities. Other modalities such as breast ultrasound and breast MRI aid in screening and examining the breast tissues in greater depth.

The global breast imaging market is estimated to be valued at US$ 4840.71 Mn in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period of 2024 to 2030.

Key Takeaways

Key players operating in the breast imaging market are Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy€TMs Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd. The growing demand for breast imaging modalities can be attributed to the rising prevalence of breast cancer worldwide. Technological advancements in devices such as 3D mammography and MRI are further expanding the capabilities of breast screening and diagnosis.

Market trends

Global Breast Imaging Market Size trends include growing adoption of digital breast tomosynthesis also known as 3D mammography. 3D mammography creates a 3D image of the breast and has demonstrated superior detection of invasive breast cancers compared to digital mammography. Another key trend is an increasing focus on developing AI and machine learning algorithms for breast cancer screening and interpretation of scans.

Market Opportunities

Breast cancer screening rates remain low in developing countries representing a major market opportunity. Governments and healthcare providers are working to spread awareness and improve accessibility of breast imaging modalities. Another opportunity lies in leveraging artificial intelligence and big data analytics to develop advanced diagnostic solutions and personalized treatment approaches for breast cancer.

Impact of COVID-19 on Breast Imaging Market

The COVID-19 pandemic has significantly impacted the growth of the breast imaging market. During the initial phase of the pandemic, the demand for breast imaging procedures declined significantly due to lockdowns and movement restrictions imposed across countries. This led to a decline in new patient registrations and procedure volumes. Hospitals diverted resources towards COVID-19 treatment and prioritized urgent cancer cases over routine screening. This period saw deferment of several screening procedures.

However, with gradual lifting of restrictions and resumption of regular healthcare services post lockdowns, the market is witnessing recovery. There is renewed focus on diagnostic screening to clear backlogs and address delayed diagnoses. Various awareness programs are being conducted to emphasize the importance of early detection of breast cancer. Medical facilities are ensuring compliance of safety protocols to instill confidence among patients and encourage them to seek timely screening. Telehealth and virtual consultations are also being leveraged to improve access.

Get More Insights On This Topic: https://medicalinfoblogs.weebly.com/blog/breast-imaging-market-will-grow-at-highest-pace-owing-to-increasing-breast-cancer-cases